VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q41685177 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000313.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q41685177‏
024 ‎‡a 0000-0003-2638-3081‏ ‎‡2 orcid‏
024 ‎‡a 24068148600‏ ‎‡2 scopus‏
024 ‎‡a 55682602500‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q41685177‏
100 0 ‎‡a Chen Wang‏ ‎‡9 ast‏ ‎‡9 es‏ ‎‡9 sl‏
400 0 ‎‡a Chen Wang‏ ‎‡c researcher ORCID: 0000-0003-2638-3081‏ ‎‡9 en‏
670 ‎‡a Author's Bioinformatics and DNA-extraction strategies to reliably detect genetic variants from FFPE breast tissue samples‏
670 ‎‡a Author's Cancer-associated stroma significantly contributes to the mesenchymal subtype signature of serous ovarian cancer‏
670 ‎‡a Author's Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C status‏
670 ‎‡a Author's Combining copy number, methylation markers, and mutations as a panel for endometrial cancer detection via intravaginal tampon collection‏
670 ‎‡a Author's Deficiency in the Repair of DNA Damage by Homologous Recombination and Sensitivity to Poly‏
670 ‎‡a Author's Deficiency in the Repair of DNA Damage by Homologous Recombination and Sensitivity to Poly(ADP-Ribose) Polymerase Inhibition‏
670 ‎‡a Author's Development and validation of the gene-expression Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE (PrOTYPE)‏
670 ‎‡a Author's Dilution of Molecular-Pathologic Gene Signatures by Medically Associated Factors Might Prevent Prediction of Resection Status After Debulking Surgery in Patients With Advanced Ovarian Cancer‏
670 ‎‡a Author's Factors that influence survival in high-grade serous ovarian cancer: A complex relationship between molecular subtype, disease dissemination, and operability‏
670 ‎‡a Author's Gene expression differences between matched pairs of ovarian cancer patient tumors and patient-derived xenografts‏
670 ‎‡a Author's Gene-expression signatures in ovarian cancer: Promise and challenges for patient stratification.‏
670 ‎‡a Author's Gene signature model for breast cancer risk prediction for women with sclerosing adenosis.‏
670 ‎‡a Author's Genes associated with bowel metastases in ovarian cancer‏
670 ‎‡a Author's Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes‏
670 ‎‡a Author's Genetic diversity of newly diagnosed follicular lymphoma‏
670 ‎‡a Author's Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk‏
670 ‎‡a Author's Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer‏
670 ‎‡a Author's Human whole genome genotype and transcriptome data for Alzheimer's and other neurodegenerative diseases‏
670 ‎‡a Author's Inherited variants in regulatory T cell genes and outcome of ovarian cancer‏
670 ‎‡a Author's Intraperitoneal disease dissemination patterns are associated with residual disease, extent of surgery, and molecular subtypes in advanced ovarian cancer‏
670 ‎‡a Author's Knowledge-guided gene ranking by coordinative component analysis‏
670 ‎‡a Author's Knowledge-guided multi-scale independent component analysis for biomarker identification‏
670 ‎‡a Author's Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome‏
670 ‎‡a Author's Leveraging a pharmacogenomics knowledgebase to formulate a drug response phenotype terminology for genomic medicine‏
670 ‎‡a Author's Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancer‏
670 ‎‡a Author's MACE: model based analysis of ChIP-exo‏
670 ‎‡a Author's Mesenchymal molecular subtype is an independent predictor of severe postoperative complications after primary debulking surgery for advanced ovarian cancer‏
670 ‎‡a Author's Molecular classification of high grade endometrioid and clear cell ovarian cancer using TCGA gene expression signatures‏
670 ‎‡a Author's Motif-directed network component analysis for regulatory network inference‏
670 ‎‡a Author's p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study‏
670 ‎‡a Author's PatternCNV: a versatile tool for detecting copy number changes from exome sequencing data.‏
670 ‎‡a Author's PO2RDF: representation of real-world data for precision oncology using resource description framework‏
670 ‎‡a Author's Prognostic and therapeutic relevance of molecular subtypes in high-grade serous ovarian cancer‏
670 ‎‡a Author's PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and <sup>68</sup> Ga-PSMA-11 PET Using Cyclotron-Produced <sup>68</sup> Ga‏
670 ‎‡a Author's RVboost: RNA-seq variants prioritization using a boosting method‏
670 ‎‡a Author's SHP2 inhibition enhances Yes-associated protein–mediated liver regeneration in murine partial hepatectomy models‏
670 ‎‡a Author's Synchronized high-resolution bed-level change and biophysical data from 10 marsh–mudflat sites in northwestern Europe‏
670 ‎‡a Author's The YAP-Interacting Phosphatase SHP2 Can Regulate Transcriptional Co-activity and Modulate Sensitivity to Chemotherapy in Cholangiocarcinoma‏
670 ‎‡a Author's Tumor hypomethylation at 6p21.3 associates with longer time to recurrence of high-grade serous epithelial ovarian cancer‏
670 ‎‡a Author's Use of FFPE-derived DNA in next generation sequencing: DNA extraction methods‏
909 ‎‡a (scopus) 24068148600‏ ‎‡9 1‏
909 ‎‡a (orcid) 0000000326383081‏ ‎‡9 1‏
909 ‎‡a (scopus) 55682602500‏ ‎‡9 1‏
912 ‎‡a developmentandvalidationofthegeneexpressionpredictorofhighgradeserousovariancarcinomamolecularsubtypeprotype‏ ‎‡A Development and validation of the gene-expression Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE (PrOTYPE)‏ ‎‡9 1‏
912 ‎‡a genomewideassociationstudyinbrca1mutationcarriersidentifiesnovellociassociatedwithbreastandovariancancerrisk‏ ‎‡A Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk‏ ‎‡9 1‏
912 ‎‡a germlinepolymorphismsinanenhancerofpsip1areassociatedwithprogressionfreesurvivalinepithelialovariancancer‏ ‎‡A Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer‏ ‎‡9 1‏
912 ‎‡a largescaleevaluationofcommonvariationinregulatorytcellrelatedgenesandovariancanceroutcome‏ ‎‡A Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome‏ ‎‡9 1‏
912 ‎‡a p53andovariancarcinomasurvivalanovariantumortissueanalysisconsortiumstudy‏ ‎‡A p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study‏ ‎‡9 1‏
919 ‎‡a bioinformaticsanddnaextractionstrategiestoreliablydetectgeneticvariantsfromffpebreasttissuesamples‏ ‎‡A Bioinformatics and DNA-extraction strategies to reliably detect genetic variants from FFPE breast tissue samples‏ ‎‡9 1‏
919 ‎‡a cancerassociatedstromasignificantlycontributestothemesenchymalsubtypesignatureofserousovariancancer‏ ‎‡A Cancer-associated stroma significantly contributes to the mesenchymal subtype signature of serous ovarian cancer‏ ‎‡9 1‏
919 ‎‡a clinicalcharacteristicsofovariancancerclassifiedbybrca1brca2andrad51cstatus‏ ‎‡A Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C status‏ ‎‡9 1‏
919 ‎‡a combiningcopynumbermethylationmarkersandmutationsasapanelforendometrialcancerdetectionviaintravaginaltamponcollection‏ ‎‡A Combining copy number, methylation markers, and mutations as a panel for endometrial cancer detection via intravaginal tampon collection‏ ‎‡9 1‏
919 ‎‡a deficiencyintherepairofdnadamagebyhomologousrecombinationandsensitivitytopoly‏ ‎‡A Deficiency in the Repair of DNA Damage by Homologous Recombination and Sensitivity to Poly‏ ‎‡9 1‏
919 ‎‡a deficiencyintherepairofdnadamagebyhomologousrecombinationandsensitivitytopolyadpribosepolymeraseinhibition‏ ‎‡A Deficiency in the Repair of DNA Damage by Homologous Recombination and Sensitivity to Poly(ADP-Ribose) Polymerase Inhibition‏ ‎‡9 1‏
919 ‎‡a dilutionofmolecularpathologicgenesignaturesbymedicallyassociatedfactorsmightpreventpredictionofresectionstatusafterdebulkingsurgeryinpatientswithadvancedovariancancer‏ ‎‡A Dilution of Molecular-Pathologic Gene Signatures by Medically Associated Factors Might Prevent Prediction of Resection Status After Debulking Surgery in Patients With Advanced Ovarian Cancer‏ ‎‡9 1‏
919 ‎‡a factorsthatinfluencesurvivalinhighgradeserousovariancanceracomplexrelationshipbetweenmolecularsubtypediseasedisseminationandoperability‏ ‎‡A Factors that influence survival in high-grade serous ovarian cancer: A complex relationship between molecular subtype, disease dissemination, and operability‏ ‎‡9 1‏
919 ‎‡a geneexpressiondifferencesbetweenmatchedpairsofovariancancerpatienttumorsandpatientderivedxenografts‏ ‎‡A Gene expression differences between matched pairs of ovarian cancer patient tumors and patient-derived xenografts‏ ‎‡9 1‏
919 ‎‡a geneexpressionsignaturesinovariancancerpromiseandchallengesforpatientstratification‏ ‎‡A Gene-expression signatures in ovarian cancer: Promise and challenges for patient stratification.‏ ‎‡9 1‏
919 ‎‡a genesignaturemodelforbreastcancerriskpredictionforwomenwithsclerosingadenosis‏ ‎‡A Gene signature model for breast cancer risk prediction for women with sclerosing adenosis.‏ ‎‡9 1‏
919 ‎‡a genesassociatedwithbowelmetastasesinovariancancer‏ ‎‡A Genes associated with bowel metastases in ovarian cancer‏ ‎‡9 1‏
919 ‎‡a genesassociatedwithhistopathologicfeaturesoftriplenegativebreasttumorspredictmolecularsubtypes‏ ‎‡A Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes‏ ‎‡9 1‏
919 ‎‡a geneticdiversityofnewlydiagnosedfollicularlymphoma‏ ‎‡A Genetic diversity of newly diagnosed follicular lymphoma‏ ‎‡9 1‏
919 ‎‡a humanwholegenomegenotypeandtranscriptomedataforalzheimersandotherneurodegenerativediseases‏ ‎‡A Human whole genome genotype and transcriptome data for Alzheimer's and other neurodegenerative diseases‏ ‎‡9 1‏
919 ‎‡a inheritedvariantsinregulatorytcellgenesandoutcomeofovariancancer‏ ‎‡A Inherited variants in regulatory T cell genes and outcome of ovarian cancer‏ ‎‡9 1‏
919 ‎‡a intraperitonealdiseasedisseminationpatternsareassociatedwithresidualdiseaseextentofsurgeryandmolecularsubtypesinadvancedovariancancer‏ ‎‡A Intraperitoneal disease dissemination patterns are associated with residual disease, extent of surgery, and molecular subtypes in advanced ovarian cancer‏ ‎‡9 1‏
919 ‎‡a knowledgeguidedgenerankingbycoordinativecomponentanalysis‏ ‎‡A Knowledge-guided gene ranking by coordinative component analysis‏ ‎‡9 1‏
919 ‎‡a knowledgeguidedmultiscaleindependentcomponentanalysisforbiomarkeridentification‏ ‎‡A Knowledge-guided multi-scale independent component analysis for biomarker identification‏ ‎‡9 1‏
919 ‎‡a leveragingapharmacogenomicsknowledgebasetoformulateadrugresponsephenotypeterminologyforgenomicmedicine‏ ‎‡A Leveraging a pharmacogenomics knowledgebase to formulate a drug response phenotype terminology for genomic medicine‏ ‎‡9 1‏
919 ‎‡a lossofhsulf1promotesalteredlipidmetabolisminovariancancer‏ ‎‡A Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancer‏ ‎‡9 1‏
919 ‎‡a macemodelbasedanalysisofchipexo‏ ‎‡A MACE: model based analysis of ChIP-exo‏ ‎‡9 1‏
919 ‎‡a mesenchymalmolecularsubtypeisanindependentpredictorofseverepostoperativecomplicationsafterprimarydebulkingsurgeryforadvancedovariancancer‏ ‎‡A Mesenchymal molecular subtype is an independent predictor of severe postoperative complications after primary debulking surgery for advanced ovarian cancer‏ ‎‡9 1‏
919 ‎‡a molecularclassificationofhighgradeendometrioidandclearcellovariancancerusingtcgageneexpressionsignatures‏ ‎‡A Molecular classification of high grade endometrioid and clear cell ovarian cancer using TCGA gene expression signatures‏ ‎‡9 1‏
919 ‎‡a motifdirectednetworkcomponentanalysisforregulatorynetworkinference‏ ‎‡A Motif-directed network component analysis for regulatory network inference‏ ‎‡9 1‏
919 ‎‡a patterncnvaversatiletoolfordetectingcopynumberchangesfromexomesequencingdata‏ ‎‡A PatternCNV: a versatile tool for detecting copy number changes from exome sequencing data.‏ ‎‡9 1‏
919 ‎‡a po2rdfrepresentationofrealworlddataforprecisiononcologyusingresourcedescriptionframework‏ ‎‡A PO2RDF: representation of real-world data for precision oncology using resource description framework‏ ‎‡9 1‏
919 ‎‡a prognosticandtherapeuticrelevanceofmolecularsubtypesinhighgradeserousovariancancer‏ ‎‡A Prognostic and therapeutic relevance of molecular subtypes in high-grade serous ovarian cancer‏ ‎‡9 1‏
919 ‎‡a psmaasatheranostictargetinhepatocellularcarcinomaimmunohistochemistryandsup68supgapsma11petusingcyclotronproducedsup68supga‏ ‎‡A PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and <sup>68</sup> Ga-PSMA-11 PET Using Cyclotron-Produced <sup>68</sup> Ga‏ ‎‡9 1‏
919 ‎‡a rvboostrnaseqvariantsprioritizationusingaboostingmethod‏ ‎‡A RVboost: RNA-seq variants prioritization using a boosting method‏ ‎‡9 1‏
919 ‎‡a shp2inhibitionenhancesyesassociatedproteinmediatedliverregenerationinmurinepartialhepatectomymodels‏ ‎‡A SHP2 inhibition enhances Yes-associated protein–mediated liver regeneration in murine partial hepatectomy models‏ ‎‡9 1‏
919 ‎‡a synchronizedhighresolutionbedlevelchangeandbiophysicaldatafrom10marshmudflatsitesinnorthwesterneurope‏ ‎‡A Synchronized high-resolution bed-level change and biophysical data from 10 marsh–mudflat sites in northwestern Europe‏ ‎‡9 1‏
919 ‎‡a yapinteractingphosphataseshp2canregulatetranscriptionalcoactivityandmodulatesensitivitytochemotherapyincholangiocarcinoma‏ ‎‡A The YAP-Interacting Phosphatase SHP2 Can Regulate Transcriptional Co-activity and Modulate Sensitivity to Chemotherapy in Cholangiocarcinoma‏ ‎‡9 1‏
919 ‎‡a tumorhypomethylationat6p213associateswithlongertimetorecurrenceofhighgradeserousepithelialovariancancer‏ ‎‡A Tumor hypomethylation at 6p21.3 associates with longer time to recurrence of high-grade serous epithelial ovarian cancer‏ ‎‡9 1‏
919 ‎‡a useofffpederiveddnainnextgenerationsequencingdnaextractionmethods‏ ‎‡A Use of FFPE-derived DNA in next generation sequencing: DNA extraction methods‏ ‎‡9 1‏
996 ‎‡2 SUDOC|094624429‏
996 ‎‡2 ISNI|0000000030046203‏
996 ‎‡2 BNF|15899153‏
996 ‎‡2 ISNI|0000000373227399‏
996 ‎‡2 LC|no2014164496‏
996 ‎‡2 ISNI|0000000064071140‏
996 ‎‡2 ISNI|0000000507434570‏
996 ‎‡2 LC|n 2001021417‏
996 ‎‡2 LNB|LNC10-000101257‏
996 ‎‡2 NUKAT|n 2005017357‏
996 ‎‡2 ISNI|0000000108211150‏
996 ‎‡2 CAOONL|ncf11890919‏
996 ‎‡2 ISNI|0000000084401215‏
996 ‎‡2 LC|no2020131609‏
996 ‎‡2 NTA|186052901‏
996 ‎‡2 KRNLK|KAC200705700‏
996 ‎‡2 NKC|jx20100804014‏
996 ‎‡2 NII|DA17748240‏
996 ‎‡2 CYT|AC000653753‏
996 ‎‡2 DNB|136659543‏
996 ‎‡2 DNB|12579200X‏
996 ‎‡2 NII|DA17221241‏
996 ‎‡2 CYT|AC000641970‏
996 ‎‡2 NTA|289172608‏
996 ‎‡2 DNB|141153016‏
996 ‎‡2 NTA|150690657‏
996 ‎‡2 CYT|AC000209659‏
996 ‎‡2 BNF|15522866‏
996 ‎‡2 NKC|xx0233735‏
996 ‎‡2 LC|n 2020031597‏
996 ‎‡2 PLWABN|9812802089205606‏
996 ‎‡2 LC|n 83185986‏
996 ‎‡2 NII|DA06901506‏
996 ‎‡2 CAOONL|ncf11356861‏
996 ‎‡2 DNB|119208474‏
996 ‎‡2 ISNI|0000000046150013‏
996 ‎‡2 LC|n 86102567‏
996 ‎‡2 PLWABN|9810607443905606‏
996 ‎‡2 SUDOC|116239875‏
996 ‎‡2 CYT|AC000000419‏
996 ‎‡2 CYT|AC000642156‏
996 ‎‡2 DNB|1317933230‏
996 ‎‡2 CYT|AC000638065‏
996 ‎‡2 J9U|987007424402605171‏
996 ‎‡2 LC|n 81039684‏
996 ‎‡2 SUDOC|151103658‏
996 ‎‡2 ISNI|0000000374792883‏
996 ‎‡2 BNF|15568970‏
996 ‎‡2 BIBSYS|4033415‏
996 ‎‡2 J9U|987011045722405171‏
996 ‎‡2 LC|n 82004313‏
996 ‎‡2 ISNI|0000000042126788‏
996 ‎‡2 ISNI|000000005303378X‏
996 ‎‡2 ISNI|0000000078346221‏
996 ‎‡2 CYT|AC000649723‏
996 ‎‡2 LC|n 82084485‏
996 ‎‡2 LC|n 88177892‏
996 ‎‡2 PLWABN|9810636727705606‏
996 ‎‡2 ISNI|0000000382248888‏
996 ‎‡2 NUKAT|n 2006107364‏
996 ‎‡2 LC|n 82095085‏
996 ‎‡2 DNB|140294929‏
996 ‎‡2 ISNI|000000004091027X‏
996 ‎‡2 LC|n 85063342‏
996 ‎‡2 LC|n 2016017754‏
996 ‎‡2 ISNI|0000000063650511‏
996 ‎‡2 LC|no 98069023‏
996 ‎‡2 CYT|AC000209310‏
996 ‎‡2 ISNI|0000000036026510‏
996 ‎‡2 ISNI|0000000079838252‏
996 ‎‡2 DNB|1317222768‏
996 ‎‡2 ISNI|0000000121353452‏
996 ‎‡2 NII|DA08770781‏
996 ‎‡2 CYT|AC000518258‏
996 ‎‡2 LC|no2010039155‏
996 ‎‡2 LC|n 88034499‏
996 ‎‡2 ISNI|0000000079347189‏
996 ‎‡2 CYT|AC000632314‏
996 ‎‡2 ISNI|0000000064021936‏
996 ‎‡2 LC|nr 95028789‏
996 ‎‡2 DNB|1250527651‏
996 ‎‡2 LC|nr 96026309‏
996 ‎‡2 J9U|987007443461605171‏
996 ‎‡2 NUKAT|n 2020147225‏
996 ‎‡2 ISNI|0000000064298521‏
996 ‎‡2 ISNI|0000000063490693‏
996 ‎‡2 ISNI|000000003714501X‏
996 ‎‡2 ISNI|0000000063304205‏
996 ‎‡2 LC|n 82270521‏
996 ‎‡2 BNF|12427641‏
996 ‎‡2 J9U|987007429088805171‏
996 ‎‡2 DNB|13782503X‏
996 ‎‡2 DNB|1267844140‏
996 ‎‡2 NUKAT|n 2017006320‏
996 ‎‡2 LC|n 87927565‏
996 ‎‡2 NTA|160581931‏
996 ‎‡2 DNB|1238296807‏
996 ‎‡2 LC|n 78086953‏
996 ‎‡2 DNB|1179222873‏
996 ‎‡2 LC|n 79110719‏
996 ‎‡2 LC|n 84074485‏
996 ‎‡2 CYT|AC000655147‏
996 ‎‡2 LC|no2015101610‏
996 ‎‡2 DNB|1336874015‏
996 ‎‡2 DNB|120134632‏
996 ‎‡2 DNB|1342256468‏
996 ‎‡2 DNB|171759893‏
996 ‎‡2 PLWABN|9812220620905606‏
996 ‎‡2 NII|DA03025438‏
996 ‎‡2 NTA|323265391‏
996 ‎‡2 DNB|1207339660‏
996 ‎‡2 LC|n 84040223‏
996 ‎‡2 SZ|1128837250‏
996 ‎‡2 NTA|364154357‏
996 ‎‡2 LC|nr 98023341‏
996 ‎‡2 ISNI|0000000081526055‏
996 ‎‡2 LC|n 2007052369‏
996 ‎‡2 DNB|1253038287‏
996 ‎‡2 LC|no2007108146‏
996 ‎‡2 LC|no2002016574‏
996 ‎‡2 BIBSYS|4079898‏
996 ‎‡2 ISNI|0000000382181636‏
996 ‎‡2 LC|no2018162932‏
996 ‎‡2 PLWABN|9812422790805606‏
996 ‎‡2 LC|nr 91016706‏
996 ‎‡2 NSK|000708028‏
996 ‎‡2 ISNI|0000000092472339‏
996 ‎‡2 ISNI|0000000063915014‏
996 ‎‡2 LC|no2020013535‏
996 ‎‡2 DNB|1190596377‏
996 ‎‡2 CAOONL|ncf11533541‏
996 ‎‡2 ISNI|0000000063412863‏
996 ‎‡2 CAOONL|ncf12003975‏
996 ‎‡2 J9U|987007440032805171‏
996 ‎‡2 ISNI|0000000063469843‏
996 ‎‡2 DNB|1204589445‏
996 ‎‡2 PLWABN|9812465493405606‏
996 ‎‡2 DNB|1342844408‏
996 ‎‡2 DNB|171025466‏
996 ‎‡2 LC|nr 91013999‏
996 ‎‡2 ISNI|0000000064353930‏
996 ‎‡2 LC|n 84027515‏
996 ‎‡2 ISNI|0000000063307772‏
996 ‎‡2 CYT|AC000007540‏
996 ‎‡2 NSK|000606449‏
996 ‎‡2 DNB|1128837250‏
996 ‎‡2 DNB|139112723‏
996 ‎‡2 ISNI|0000000063449447‏
996 ‎‡2 CYT|AC000007549‏
996 ‎‡2 DNB|1137537302‏
996 ‎‡2 CYT|AC000229160‏
996 ‎‡2 SUDOC|192906518‏
996 ‎‡2 J9U|987007386073105171‏
996 ‎‡2 DNB|1297555783‏
996 ‎‡2 DNB|1277885397‏
996 ‎‡2 ISNI|0000000063487208‏
996 ‎‡2 LC|n 79108476‏
996 ‎‡2 DNB|140944435‏
996 ‎‡2 BIBSYS|90333524‏
996 ‎‡2 LC|n 85308961‏
996 ‎‡2 CYT|AC000654411‏
996 ‎‡2 BIBSYS|3007962‏
996 ‎‡2 LC|no2005057605‏
996 ‎‡2 SUDOC|245170308‏
996 ‎‡2 LC|n 82020931‏
996 ‎‡2 LC|no 89007032‏
996 ‎‡2 LC|n 95033847‏
996 ‎‡2 RERO|A003957674‏
996 ‎‡2 LC|nr 91005302‏
996 ‎‡2 ISNI|0000000419498232‏
996 ‎‡2 BNF|17087653‏
996 ‎‡2 DNB|1218263067‏
996 ‎‡2 DNB|1279308192‏
996 ‎‡2 NTA|153471174‏
996 ‎‡2 LC|no2023112338‏
996 ‎‡2 CYT|AC000209274‏
996 ‎‡2 CYT|AC000209277‏
996 ‎‡2 CYT|AC000209278‏
996 ‎‡2 LC|n 80088313‏
996 ‎‡2 DNB|1044806982‏
996 ‎‡2 PLWABN|9810560674605606‏
996 ‎‡2 DNB|11901291X‏
996 ‎‡2 LC|n 88246084‏
996 ‎‡2 LC|n 94118492‏
996 ‎‡2 BNF|16132784‏
996 ‎‡2 LC|no2022097606‏
996 ‎‡2 DNB|1218263261‏
996 ‎‡2 NDL|001299551‏
996 ‎‡2 DNB|1175393819‏
996 ‎‡2 ISNI|0000000063135405‏
996 ‎‡2 LC|n 2022055852‏
996 ‎‡2 DNB|1277190402‏
996 ‎‡2 LC|nr 98013114‏
996 ‎‡2 NII|DA1171002X‏
996 ‎‡2 DNB|1077204574‏
996 ‎‡2 CYT|AC000659449‏
996 ‎‡2 ISNI|0000000053894934‏
996 ‎‡2 LC|n 88243347‏
996 ‎‡2 LC|n 83205645‏
996 ‎‡2 LC|n 85213841‏
996 ‎‡2 LC|n 80005963‏
996 ‎‡2 ISNI|0000000381893797‏
996 ‎‡2 LC|no 98027666‏
996 ‎‡2 DNB|1037280954‏
996 ‎‡2 CYT|AC000556615‏
996 ‎‡2 LC|no2020013360‏
996 ‎‡2 LC|n 96107663‏
996 ‎‡2 DNB|1208705946‏
996 ‎‡2 DNB|123222054X‏
996 ‎‡2 LC|n 87857603‏
996 ‎‡2 DNB|1308506414‏
996 ‎‡2 NTA|242473776‏
996 ‎‡2 NSK|000677610‏
996 ‎‡2 LC|n 2001053316‏
996 ‎‡2 LC|n 85009865‏
996 ‎‡2 LC|nr 93031217‏
996 ‎‡2 NII|DA08210186‏
996 ‎‡2 CYT|AC000631402‏
996 ‎‡2 NSK|000009509‏
996 ‎‡2 SUDOC|069065780‏
996 ‎‡2 LC|nr 96002037‏
996 ‎‡2 ISNI|0000000064239871‏
996 ‎‡2 LC|no 97054995‏
996 ‎‡2 NTA|364156597‏
996 ‎‡2 CYT|AC000642314‏
996 ‎‡2 RERO|A005490678‏
996 ‎‡2 DNB|1223994872‏
996 ‎‡2 NTA|364154160‏
996 ‎‡2 DNB|1020798394‏
996 ‎‡2 CYT|AC000618070‏
996 ‎‡2 SUDOC|17690770X‏
996 ‎‡2 CYT|AC000259042‏
996 ‎‡2 DNB|1289647771‏
996 ‎‡2 CYT|AC000653782‏
996 ‎‡2 LC|n 83050643‏
996 ‎‡2 SUDOC|224228315‏
996 ‎‡2 SUDOC|190565519‏
996 ‎‡2 SUDOC|122516117‏
996 ‎‡2 RERO|A024005613‏
996 ‎‡2 ISNI|0000000064264962‏
996 ‎‡2 RERO|A025739942‏
996 ‎‡2 ISNI|0000000064356867‏
996 ‎‡2 DNB|136272061‏
996 ‎‡2 DNB|1345709471‏
996 ‎‡2 SUDOC|176164839‏
996 ‎‡2 DNB|143430726‏
996 ‎‡2 CYT|AC000653232‏
996 ‎‡2 ISNI|000000007739095X‏
996 ‎‡2 ISNI|0000000064122454‏
996 ‎‡2 DNB|142636185‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏
998 ‎‡a Chen,‏ ‎‡b Wang‏ ‎‡2 PTBNP|1739103‏ ‎‡3 exact name‏
998 ‎‡a Chen, Wang‏ ‎‡2 LC|n 2018029858‏ ‎‡3 exact name‏
998 ‎‡a Chen‏ ‎‡b Wang‏ ‎‡2 LIH|LNB:C0B1;=_c_,‏ ‎‡3 exact name‏
998 ‎‡a Chen, Wang‏ ‎‡2 BIBSYS|1688706555319‏ ‎‡3 exact name‏